Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States

PloS One
Donna SweetBjörn Vandewalle

Abstract

The possibility of incorporating generics into combination antiretroviral therapy and breaking apart once-daily single-tablet regimens (STRs), may result in less efficacious medications and/or more complex regimens with the expectation of marked monetary savings. A modeling approach that assesses the merits of such policies in terms of lifelong costs and health outcomes using adherence and effectiveness data from real-world U.S. settings. A comprehensive computer-based microsimulation model was developed to assess the lifetime health (life expectancy and quality adjusted life-years--QALYs) and economic outcomes in HIV-1 infected patients initiating STRs compared with multiple-table regimens including generic medications where possible (gMTRs). The STRs considered included tenofovir disoproxil fumarate/emtricitabine and efavirenz or rilpivirine or elvitegravir/cobicistat. gMTRs substitutions included each counterpart to STRs, including generic lamivudine for emtricitabine and generic versus branded efavirenz. Life expectancy is estimated to be 1.301 years higher (discounted 0.619 QALY gain) in HIV-1 patients initiating a single-tablet regimen in comparison to a generic-based multiple-table regimen. STRs were associated with an a...Continue Reading

References

Mar 29, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·C A SabinC Loveday
Nov 26, 2003·The Journal of Infectious Diseases·Franck S RousseauUNKNOWN FTC-102 Clinical Trial Group
Jul 14, 2004·JAMA : the Journal of the American Medical Association·Joel E GallantUNKNOWN 903 Study Group
Nov 11, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Benoit TrottierMiklos P Salgo
Sep 28, 2006·JAMA : the Journal of the American Medical Association·Benigno RodríguezMichael M Lederman
Oct 26, 2006·Medical Care·Bruce R SchackmanKenneth A Freedberg
Jan 18, 2007·Annals of Internal Medicine·Nicolai LohseNiels Obel
Apr 7, 2007·AIDS·Richard HaubrichUNKNOWN POWER 2 Study Group
Apr 18, 2007·Annals of Internal Medicine·Jean B NachegaGary Maartens
May 23, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Teresa L KaufChristopher Nimsch
Jan 26, 2010·AIDS·Edward M GardnerUNKNOWN Terry Beirn Community Programs for Clinical Research on AIDS and the International Network for Strategic Initiatives in Glob
Sep 23, 2010·AIDS·Kelly A GeboUNKNOWN HIV Research Network
May 26, 2011·Medical Care·Paul G BarnettDouglas K Owens
Oct 20, 2011·AIDS·Caroline E SloanUNKNOWN Cost-Effectiveness of Preventing AIDS Complications (CEPAC) investigators
Dec 14, 2011·ClinicoEconomics and Outcomes Research : CEOR·Giorgio L ColomboPierluigi Viale
Jul 24, 2012·JAMA : the Journal of the American Medical Association·Melanie A ThompsonPaul A Volberding
Aug 14, 2012·ClinicoEconomics and Outcomes Research : CEOR·Brian GazzardAndrew Hill
Jan 16, 2013·Annals of Internal Medicine·Rochelle P WalenskyBruce R Schackman
Feb 23, 2013·ClinicoEconomics and Outcomes Research : CEOR·Giorgio L ColomboFranco Maggiolo
May 25, 2013·The Journal of Infectious Diseases·Mina C HosseinipourJean B Nachega
Jul 23, 2013·PDA Journal of Pharmaceutical Science and Technology·Govind Rao
Dec 25, 2013·PloS One·Hasina SamjiUNKNOWN North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
Jan 25, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean B NachegaThomas P Giordano
May 29, 2014·PloS One·Caitlyn T SolemKit Simpson
Aug 28, 2014·The New England Journal of Medicine·Peter J NeumannMilton C Weinstein
Oct 24, 2014·Emerging Infectious Diseases·Diana KhuuFrank Sorvillo
Nov 14, 2014·Journal of the International AIDS Society·Donna SweetJames Signorovitch
Feb 19, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Casper Rokx, Bart J A Rijnders

❮ Previous
Next ❯

Citations

Sep 25, 2018·Journal of Managed Care & Specialty Pharmacy·Richard E NelsonJoanne LaFleur
Jan 24, 2019·Journal of the International Association of Providers of AIDS Care·Hartmut KrentzJohn Gill
Jun 21, 2017·International Journal of STD & AIDS·Jennifer A KieranAisling O'Leary
Feb 6, 2020·Journal of Managed Care & Specialty Pharmacy·Thomas WardAlan Oglesby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
R YagudinaV V Babiy
Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria
L C Fernández LisónC Bocanegra Martín
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Robert R Redfield, J Scott Morrow
© 2021 Meta ULC. All rights reserved